\section{Additional details for sepsis experiments}
\label{app:sepsis-details}


\subsection{Sepsis data and cohort details}
\label{app:sepsis-dataset}

We followed the pre-processing methodology from \cite{tang2020clinician, komorowski2018artificial} and we refer the reader to the original work for more details. 


The dosage of prescribed IV fluids and vasopressors is converted into discrete variables to be used as actions for the constructed MDP. Each type of action (IV or vasopressor) is divided into 4 bins (each representing one quantile), and an additional action for "No drug" (0 dose) is also introduced. As such, the $|\A| = 5 \times 5$.
The cohort statistics can be found in \Cref{table:cohort-stats}. The patient data consists of 48 dimensional time-series with features representing attributes such as demographics, vitals and lab work results (\Cref{table:sepsis-features-summary}). 
The patient data is discretized into 4-hour windows, each of which is pre-processed to be treated as a single time-step. The state-space and is discretized using a k-means based clustering algorithm to map the states to $750$ clusters. Two additional absorbing states are added for death and survival ($|\X|=752$).

\begin{table}[h]
    \centering
    \caption{Cohort statistics after following the data pre-processing methodology from \cite{tang2020clinician, komorowski2018artificial}.}
    \label{table:cohort-stats}
    \vskip 0.1in
    \begin{tabular}{lrrrr}
    \toprule
     Survivors &     N & \% Female & Mean Age & Hours in ICU \\
    \midrule
     Survivors & 18066 &    44.5\% &     64.1 &         56.6 \\
    Non-survivors &  2888 &    42.9\% &     68.8 &         60.9 \\
    \bottomrule
\end{tabular}
\end{table}

% The duration of an episode consists of 28 hours data before the onset of sepsis, and 52 hours data after that, leading to a maximum of 20 time-steps for each trajectory. 

\begin{table*}[h]
    \centering
    \caption{Summary of the patient state features from \citep[][Table 3]{tang2020clinician}.}
    \label{table:sepsis-features-summary}
    \begin{tabular}{lp{9cm}}
        \toprule
        Demographics/Static &  Age, Gender, SOFA, Shock Index, Elixhauser, SIRS, Re-admission, GCS - Glasgow Coma Scale \\
        \midrule
        Lab values & Albumin, Arterial pH, Calcium, Glucose, Hemoglobin, Magnesium, PTT - Partial Thromboplastin Time, Potassium, SGPT - Serum Glutamic-Pyruvic Transaminase, Arterial Blood Gas, Blood Urea Nitrogen, Chloride, Bicarbonate, International Normalized Ratio, Sodium, Arterial Lactate, CO2, Creatinine, Ionised Calcium, Prothrombin Time, Platelets Count, SGOT - Serum Glutamic-Oxaloacetic Transaminase, Total bilirubin, White Blood Cell Count \\
        \midrule
        Vital signs & Diastolic Blood Pressure, Systolic Blood Pressure, Mean Blood Pressure, PaCO2, PaO2, FiO2, PaO/FiO2 ratio, Respiratory Rate, Temperature (Celsius), Weight (kg), Heart Rate, SpO2 \\
        \midrule
        Intake and output events & Fluid Output - 4 hourly period, Total Fluid Output, Mechanical Ventilation \\
        \bottomrule
    \end{tabular}

\end{table*}




\subsection{Performance on changing hyper-parameters}
\label{app:sepsis-hyperparams}

For the experiments in \Cref{sec:sepsis-experiments}, we treat $\delta$ as a hyper-parameter. For \ref{eq:s-opt} instead of searching over both $\delta$ and $\epsilon$, we follow the strategy proposed in Soft-SPIBB: fix the $\delta=1.0$ and only search over $\epsilon$. 
For \ref{eq:h-opt}, we found that only DR and WDR gave reliable off-policy estimates so report the results with both of them with different $\delta$. As in previous sections, we used student's t-test as the choice of concentration inequality for \ref{eq:h-opt}.



% ------------------------------------------------------
%                   S-OPT
% ------------------------------------------------------
\subsubsection{\ref{eq:s-opt} parameters}

Here, we fix $\delta=1.0$ and try with different values of the hyper-parameter $\epsilon$ and directly report the results directly on the test set. The results are presented in \Cref{table:app-s-opt-test}.


% ------------------------------------------------------
%                   H-OPT
% ------------------------------------------------------
\subsubsection{\ref{eq:h-opt} parameters}


We run with different values of the hyper-parameter $\delta$ and directly report the results directly on the test set for different $\IS$ estimators. The results for DR estimator are presented in \Cref{table:app-hopt-DR-Adv} and for WDR estimator are presented in \Cref{table:app-hopt-WDR-Adv}.




% ------------------------------------------------------
%                   Additional Details 
% ------------------------------------------------------


\subsection{Additional qualitative Analysis}
\label{app:sepsis-qual-analysis}
We calculate how many rare-actions are recommended by different solution policies and compare them with the most common actions taken by the clinicians.
For each state, for the action recommended by a solution policy, we calculate the frequency with which that state-action was observed in the training data and calculate the percentage of time that state-action pair was observed among all the possible actions taken from that state.
Across all the states, the actions suggested by the traditional single-objective RL baseline are observed only 3\% of the time on average (5.3 observations per state). Whereas, the actions most commonly chosen by the clinicians  are observed 51.4\% of the time on average (138.2 observations per state). We study this behavior for two of the policies returned by MO-SPIBB that deviate the most from the baseline: for the policy returned by \ref{eq:s-opt} ($\bml=[1,1]$) the recommended actions are observed 24.8\% of time on average (61.0 observations per state) and for  \ref{eq:s-opt} ($\bml=[0,1]$) the recommended actions are observed 23.4\% of times (56.14 observations per state).


\subsection{Additional details}

For the experiments in \Cref{sec:sepsis-experiments}, on an Intel(R) Xeon(R) Gold 6230 CPU (2.10GHz), running the Linearized baseline takes around 30 seconds, Adv-Linearized takes around 60 seconds, \ref{eq:s-opt} take about 90-120 seconds and \ref{eq:h-opt} takes about 90 seconds.


% ------------------------------------------------------
%                   Tables
% ------------------------------------------------------

% ------- S-OPT ---------
\begin{table}[h]
    \centering
    \caption{
    Performance of various \ref{eq:s-opt} policy candidates (with different $\epsilon$) using DR and WDR estimation with standard errors on 10 random splits of the TEST dataset. 
    The red cells denote the corresponding safety constraint violation, i.e, either $\mathcal{J}_{0}^{\pi} < \mathcal{J}_{0}^{\pib}$ or $-\mathcal{J}_{1}^{\pi} > -\mathcal{J}_{1}^{\pib}$.}
    \label{table:app-s-opt-test}
    \vskip 0.1in
    % \small
    % \begin{longtable}{cccccc}
    \begin{adjustbox}{max width=1\textwidth,center}
    \begin{tabular}{cccccc}
    % \begin{longtable}{Y{1cm}Y{1cm}Y{2cm}Y{2cm}Y{2cm}Y{2cm}}
    \toprule
    \multicolumn{1}{c}{User preferences $(\bml)$} & \multicolumn{1}{c}{Policy} & \multicolumn{2}{c}{Survival return ($\mathcal{J}_0$)} & \multicolumn{2}{c}{Rare-treatment return ($- \mathcal{J}_1$)} \\
    \hline
    & & DR & WDR & DR & WDR  \\  \cline{3-6}
    & Clinician's ($\pib$) & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90          & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19  \\
    \midrule
    % ------ [1, 0] -------
    \multirow{4}{*}{$[\lambda_0=1.0, \lambda_1 = 0.0]$} 
& Linearized & 97.68 $\pm$ 0.22 & 97.58 $\pm$ 0.20   & \textcolor{red}{27.64 $\pm$ 1.11 }& \textcolor{red}{27.84 $\pm$ 1.09 } \\ 
& \ref{eq:s-opt}, $\epsilon=0.0$  & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90   & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19  \\
& \ref{eq:s-opt}, $\epsilon=0.001$  & 64.91 $\pm$ 0.90 & 64.91 $\pm$ 0.90   & 13.56 $\pm$ 0.19 & 13.56 $\pm$ 0.19  \\
& \ref{eq:s-opt}, $\epsilon=0.01$  & 66.11 $\pm$ 0.87 & 66.05 $\pm$ 0.86   & 13.42 $\pm$ 0.20 & 13.46 $\pm$ 0.20  \\
& \ref{eq:s-opt}, $\epsilon=0.1$  & 73.70 $\pm$ 0.84 & 71.96 $\pm$ 0.69   & 12.30 $\pm$ 0.39 & \textcolor{red}{13.80 $\pm$ 0.33 }  \\
& \ref{eq:s-opt}, $\epsilon=0.5$  & 78.19 $\pm$ 0.54 & 81.01 $\pm$ 0.36   & \textcolor{red}{16.21 $\pm$ 0.49 }& 13.10 $\pm$ 0.31  \\
& \ref{eq:s-opt}, $\epsilon=1.0$  & 84.03 $\pm$ 0.48 & 87.11 $\pm$ 0.33   & \textcolor{red}{15.54 $\pm$ 0.59 }& 12.17 $\pm$ 0.59  \\
& \ref{eq:s-opt}, $\epsilon=2.5$  & 90.05 $\pm$ 0.25 & 91.37 $\pm$ 0.20   & \textcolor{red}{15.35 $\pm$ 0.72 }& 13.53 $\pm$ 0.56  \\
& \ref{eq:s-opt}, $\epsilon=5.0$  & 91.58 $\pm$ 0.49 & 92.66 $\pm$ 0.28   & \textcolor{red}{15.39 $\pm$ 0.59 }& \textcolor{red}{13.71 $\pm$ 0.38 }\\
& \ref{eq:s-opt}, $\epsilon=10.0$  & 91.64 $\pm$ 0.47 & 92.68 $\pm$ 0.23   & \textcolor{red}{15.19 $\pm$ 0.59 }& 13.56 $\pm$ 0.42  \\
& \ref{eq:s-opt}, $\epsilon=\infty$  & 91.62 $\pm$ 0.46 & 92.68 $\pm$ 0.23   & \textcolor{red}{15.18 $\pm$ 0.59 }& 13.56 $\pm$ 0.42  \\
    \midrule
    % --------- [1, 1] -------------
    \multirow{4}{*}{$[\lambda_0=1.0, \lambda_1 = 1.0]$}
    & Linearized & 87.17 $\pm$ 0.48 & 89.11 $\pm$ 0.37   & 2.41 $\pm$ 0.47 & 1.52 $\pm$ 0.41\\
& \ref{eq:s-opt}, $\epsilon=0.0$  & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90   & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19\\
& \ref{eq:s-opt}, $\epsilon=0.001$  & 64.90 $\pm$ 0.90 & 64.90 $\pm$ 0.90   & 13.53 $\pm$ 0.19 & 13.54 $\pm$ 0.19\\
& \ref{eq:s-opt}, $\epsilon=0.01$  & 66.02 $\pm$ 0.88 & 65.94 $\pm$ 0.87   & 13.15 $\pm$ 0.20 & 13.20 $\pm$ 0.20\\
& \ref{eq:s-opt}, $\epsilon=0.1$  & 74.34 $\pm$ 0.78 & 72.04 $\pm$ 0.87   & 9.32 $\pm$ 0.29 & 10.48 $\pm$ 0.45\\
& \ref{eq:s-opt}, $\epsilon=0.5$  & 76.47 $\pm$ 0.50 & 78.42 $\pm$ 0.41   & 7.61 $\pm$ 0.44 & 5.02 $\pm$ 0.17\\
& \ref{eq:s-opt}, $\epsilon=1.0$  & 81.39 $\pm$ 0.46 & 84.54 $\pm$ 0.36   & 4.64 $\pm$ 0.40 & 2.38 $\pm$ 0.22 \\
& \ref{eq:s-opt}, $\epsilon=2.5$  & 86.26 $\pm$ 0.33 & 88.09 $\pm$ 0.24   & 1.98 $\pm$ 0.28 & 1.14 $\pm$ 0.27  \\
& \ref{eq:s-opt}, $\epsilon=5.0$  & 86.76 $\pm$ 0.47 & 88.55 $\pm$ 0.22   & 2.52 $\pm$ 0.48 & 1.55 $\pm$ 0.41\\
& \ref{eq:s-opt}, $\epsilon=10.0$  & 86.77 $\pm$ 0.49 & 88.58 $\pm$ 0.25   & 2.53 $\pm$ 0.50 & 1.57 $\pm$ 0.43  \\
& \ref{eq:s-opt}, $\epsilon=\infty$  & 86.77 $\pm$ 0.49 & 88.58 $\pm$ 0.25   & 2.53 $\pm$ 0.50 & 1.57 $\pm$ 0.43  \\
    \midrule
    % --------- [0, 0] ------------
    \multirow{4}{*}{$[\lambda_0=0.0, \lambda_1 = 0.0]$}
    & Linearized & \textcolor{red}{-89.39 $\pm$ 0.43} & \textcolor{red}{-90.90 $\pm$ 0.29 }  & \textcolor{red}{22.99 $\pm$ 0.40 }& \textcolor{red}{22.81 $\pm$ 0.30 }  \\ 
    & \ref{eq:s-opt}, $\epsilon=0.0$  & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90   & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19\\
& \ref{eq:s-opt}, $\epsilon=0.001$  & 64.80 $\pm$ 0.90 & 64.80 $\pm$ 0.90   & 13.57 $\pm$ 0.19 & 13.57 $\pm$ 0.19\\
& \ref{eq:s-opt}, $\epsilon=0.01$  & 64.92 $\pm$ 0.90 & 64.92 $\pm$ 0.90   & 13.50 $\pm$ 0.19 & 13.51 $\pm$ 0.19\\
& \ref{eq:s-opt}, $\epsilon=0.1$  & 65.78 $\pm$ 0.89 & 65.70 $\pm$ 0.88   & 13.20 $\pm$ 0.20 & 13.25 $\pm$ 0.20  \\
& \ref{eq:s-opt}, $\epsilon=0.5$  & 67.73 $\pm$ 0.82 & 67.22 $\pm$ 0.88   & 13.24 $\pm$ 0.24 & 13.55 $\pm$ 0.33\\
& \ref{eq:s-opt}, $\epsilon=1.0$  & 69.12 $\pm$ 0.75 & 67.90 $\pm$ 0.84   & 13.57 $\pm$ 0.27 & \textcolor{red}{14.39 $\pm$ 0.44 }\\
& \ref{eq:s-opt}, $\epsilon=2.5$  & 71.00 $\pm$ 0.63 & 68.28 $\pm$ 0.46   & \textcolor{red}{14.27 $\pm$ 0.30 }& \textcolor{red}{15.73 $\pm$ 0.40 }  \\
& \ref{eq:s-opt}, $\epsilon=5.0$  & 71.95 $\pm$ 0.54 & 69.27 $\pm$ 0.63   & \textcolor{red}{15.29 $\pm$ 0.39 }& \textcolor{red}{16.12 $\pm$ 0.70 }  \\
& \ref{eq:s-opt}, $\epsilon=10.0$  & 72.73 $\pm$ 0.64 & 71.17 $\pm$ 0.65   & \textcolor{red}{16.59 $\pm$ 0.37 }& \textcolor{red}{16.21 $\pm$ 0.41 }\\
& \ref{eq:s-opt}, $\epsilon=\infty$  & \textcolor{red}{60.27 $\pm$ 0.49} & \textcolor{red}{61.44 $\pm$ 0.85 }  & \textcolor{red}{18.40 $\pm$ 0.27 }& \textcolor{red}{15.36 $\pm$ 0.58 }  \\
    \midrule
    % ------- [0,1]
    \multirow{4}{*}{$[\lambda_0=0.0, \lambda_1 = 1.0]$}
& Linearized & \textcolor{red}{58.27 $\pm$ 2.18} & \textcolor{red}{60.52 $\pm$ 2.07 }  & 0.04 $\pm$ 0.03 & 0.02 $\pm$ 0.01  \\ 
    & \ref{eq:s-opt}, $\epsilon=0.0$  & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90   & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19  \\
& \ref{eq:s-opt}, $\epsilon=0.001$  & 64.83 $\pm$ 0.90 & 64.83 $\pm$ 0.90   & 13.52 $\pm$ 0.19 & 13.52 $\pm$ 0.19  \\
 & \ref{eq:s-opt}, $\epsilon=0.01$  & 65.36 $\pm$ 0.88 & 65.27 $\pm$ 0.88   & 12.96 $\pm$ 0.19 & 13.01 $\pm$ 0.19  \\
 & \ref{eq:s-opt}, $\epsilon=0.1$  & 71.35 $\pm$ 0.96 & 69.29 $\pm$ 0.92   & 7.75 $\pm$ 0.19 & 8.30 $\pm$ 0.18\\
 & \ref{eq:s-opt}, $\epsilon=0.5$  & 71.01 $\pm$ 0.72 & 71.30 $\pm$ 0.68   & 2.54 $\pm$ 0.37 & 1.50 $\pm$ 0.11  \\
 & \ref{eq:s-opt}, $\epsilon=1.0$  & 74.19 $\pm$ 0.57 & 76.11 $\pm$ 0.57   & 0.90 $\pm$ 0.14 & 0.34 $\pm$ 0.09  \\
 & \ref{eq:s-opt}, $\epsilon=2.5$  & 76.42 $\pm$ 0.61 & 77.20 $\pm$ 0.72   & 0.10 $\pm$ 0.06 & 0.06 $\pm$ 0.04  \\
 & \ref{eq:s-opt}, $\epsilon=5.0$  & 76.08 $\pm$ 0.65 & 76.87 $\pm$ 0.74   & 0.07 $\pm$ 0.05 & 0.05 $\pm$ 0.03\\
 & \ref{eq:s-opt}, $\epsilon=10.0$  & 76.07 $\pm$ 0.65 & 76.87 $\pm$ 0.73   & 0.07 $\pm$ 0.05 & 0.04 $\pm$ 0.03\\
 & \ref{eq:s-opt}, $\epsilon=\infty$  & 76.05 $\pm$ 0.65 & 76.85 $\pm$ 0.72   & 0.07 $\pm$ 0.05 & 0.04 $\pm$ 0.03\\
 \bottomrule
    \addtocounter{table}{-1} % to decrease the counter 
    % \end{longtable}
    \end{tabular}
    \end{adjustbox}
\end{table}


% ------- DR ---------
\begin{table}[h]
    \centering
    \caption{
    Performance of various \ref{eq:h-opt} policy candidates (with different $\delta$) using $\IS=$ DR estimator with standard errors on 10 random splits of the TEST dataset. 
    The red cells denote the corresponding safety constraint violation, i.e, either $\mathcal{J}_{0}^{\pi} < \mathcal{J}_{0}^{\pib}$ or $-\mathcal{J}_{1}^{\pi} > -\mathcal{J}_{1}^{\pib}$.}
    \label{table:app-hopt-DR-Adv}
    \vskip 0.1in
    \begin{adjustbox}{max width=1\textwidth,center}
    \begin{tabular}{cccccc}
    % \begin{longtable}{cccccc}
    \toprule
    \multicolumn{1}{c}{User preferences $(\bml)$} & \multicolumn{1}{c}{Policy} & \multicolumn{2}{c}{Survival return ($\mathcal{J}_0$)} & \multicolumn{2}{c}{Rare-treatment return ($- \mathcal{J}_1$)} \\
    \hline
    & & DR & WDR & DR & WDR  \\  \cline{3-6}
    & Clinician's ($\pib$) & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90          & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19  \\
    \midrule
    % ------ [1, 0] -------
    \multirow{4}{*}{$[\lambda_0=1.0, \lambda_1 = 0.0]$} 
    & Linearized & 97.68 $\pm$ 0.22 & 97.58 $\pm$ 0.20   & \textcolor{red}{27.64 $\pm$ 1.11 }& \textcolor{red}{27.84 $\pm$ 1.09 } \\ 
    & \ref{eq:h-opt}, $\delta=0.1$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt},  $\delta=0.3$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.7$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    \midrule
    % --------- [1, 1] -------------
    \multirow{4}{*}{$[\lambda_0=1.0, \lambda_1 = 1.0]$}
    & Linearized & 87.17 $\pm$ 0.48 & 89.11 $\pm$ 0.37   & 2.41 $\pm$ 0.47 & 1.52 $\pm$ 0.41\\
    & \ref{eq:h-opt}, $\delta=0.1$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.3$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.7$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00  \\
    \midrule
    % --------- [0, 0] ------------
    \multirow{4}{*}{$[\lambda_0=0.0, \lambda_1 = 0.0]$}
    & Linearized & \textcolor{red}{-89.39 $\pm$ 0.43} & \textcolor{red}{-90.90 $\pm$ 0.29 }  & \textcolor{red}{22.99 $\pm$ 0.40 }& \textcolor{red}{22.81 $\pm$ 0.30 }  \\ 
    & \ref{eq:h-opt}, $\delta=0.1$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00  \\
    & \ref{eq:h-opt}, $\delta=0.3$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.7$  & 68.28 $\pm$ 0.00 & \textcolor{red}{63.25 $\pm$ 0.00 }  & \textcolor{red}{14.16 $\pm$ 0.00 }& \textcolor{red}{16.41 $\pm$ 0.00 } \\
    & \ref{eq:h-opt}, $\delta=0.9$  & 68.28 $\pm$ 0.00 & \textcolor{red}{63.25 $\pm$ 0.00 }  & \textcolor{red}{14.16 $\pm$ 0.00 }& \textcolor{red}{16.41 $\pm$ 0.00 }\\
    \midrule
    % ------- [0,1]
    \multirow{4}{*}{$[\lambda_0=0.0, \lambda_1 = 1.0]$}
    & Linearized & \textcolor{red}{58.27 $\pm$ 2.18} & \textcolor{red}{60.52 $\pm$ 2.07 }  & 0.04 $\pm$ 0.03 & 0.02 $\pm$ 0.01  \\ 
    & \ref{eq:h-opt}, $\delta=0.1$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.3$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.7$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00  \\
    \bottomrule
    \addtocounter{table}{-1} % to decrease the counter 
    % \end{longtable}
    \end{tabular}
    \end{adjustbox}
\end{table}




% ------- WDR ------------
\begin{table}[h]
    \centering
    \caption{
    Performance of various \ref{eq:h-opt} policy candidates (with different $\delta$) using $\IS=$Weighed DR (WDR) estimator with standard errors on 10 random splits of the TEST dataset. 
    The red cells denote the corresponding safety constraint violation, i.e, either $\mathcal{J}_{0}^{\pi} < \mathcal{J}_{0}^{\pib}$ or $-\mathcal{J}_{1}^{\pi} > -\mathcal{J}_{1}^{\pib}$.}
    \label{table:app-hopt-WDR-Adv}
    \vskip 0.1in
    \begin{adjustbox}{max width=1\textwidth,center}
    \begin{tabular}{cccccc}
    \toprule
    \multicolumn{1}{c}{User preferences $(\bml)$} & \multicolumn{1}{c}{Policy} & \multicolumn{2}{c}{Survival return ($\mathcal{J}_0$)} & \multicolumn{2}{c}{Rare-treatment return ($- \mathcal{J}_1$)} \\
    \hline
    & & DR & WDR & DR & WDR  \\  \cline{3-6}
    & Clinician's ($\pib$) & 64.78 $\pm$ 0.90 & 64.78 $\pm$ 0.90          & 13.58 $\pm$ 0.19 & 13.58 $\pm$ 0.19  \\
    \midrule
    % ------ [1, 0] -------
    \multirow{4}{*}{$[\lambda_0=1.0, \lambda_1 = 0.0]$} 
    & Linearized & 97.68 $\pm$ 0.22 & 97.58 $\pm$ 0.20   & \textcolor{red}{27.64 $\pm$ 1.11 }& \textcolor{red}{27.84 $\pm$ 1.09 } \\ 
    & \ref{eq:h-opt}, $\delta=0.1$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.3$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.7$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 91.39 $\pm$ 0.00 & 92.61 $\pm$ 0.00   & \textcolor{red}{15.41 $\pm$ 0.00 }& \textcolor{red}{13.89 $\pm$ 0.00 } \\
    \midrule
    % --------- [1, 1] -------------
    \multirow{4}{*}{$[\lambda_0=1.0, \lambda_1 = 1.0]$}
    & Linearized & 87.17 $\pm$ 0.48 & 89.11 $\pm$ 0.37   & 2.41 $\pm$ 0.47 & 1.52 $\pm$ 0.41\\
    & \ref{eq:h-opt}, $\delta=0.1$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.3$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00  \\
    & \ref{eq:h-opt}, $\delta=0.7$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 86.37 $\pm$ 0.00 & 88.03 $\pm$ 0.00   & 2.58 $\pm$ 0.00 & 1.43 $\pm$ 0.00\\
    \midrule
    % --------- [0, 0] ------------
    \multirow{4}{*}{$[\lambda_0=0.0, \lambda_1 = 0.0]$}
    & Linearized & \textcolor{red}{-89.39 $\pm$ 0.43} & \textcolor{red}{-90.90 $\pm$ 0.29 }  & \textcolor{red}{22.99 $\pm$ 0.40 }& \textcolor{red}{22.81 $\pm$ 0.30 }  \\ 
    & \ref{eq:h-opt}, $\delta=0.1$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00  \\
    & \ref{eq:h-opt}, $\delta=0.3$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00  \\
    & \ref{eq:h-opt}, $\delta=0.7$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 65.95 $\pm$ 0.00 & 65.95 $\pm$ 0.00   & 13.37 $\pm$ 0.00 & 13.37 $\pm$ 0.00  \\
    \midrule
    % ------- [0,1]
    \multirow{4}{*}{$[\lambda_0=0.0, \lambda_1 = 1.0]$}
    & Linearized & \textcolor{red}{58.27 $\pm$ 2.18} & \textcolor{red}{60.52 $\pm$ 2.07 }  & 0.04 $\pm$ 0.03 & 0.02 $\pm$ 0.01  \\ 
    & \ref{eq:h-opt}, $\delta=0.1$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.3$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.5$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.7$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    & \ref{eq:h-opt}, $\delta=0.9$  & 76.54 $\pm$ 0.00 & 77.55 $\pm$ 0.00   & 0.09 $\pm$ 0.00 & 0.05 $\pm$ 0.00\\
    \bottomrule
    \addtocounter{table}{-1} % to decrease the counter 
    \end{tabular}
    \end{adjustbox}
\end{table}
